Variant report

Variant	nsv596200
Chromosome Location	chr4:172932137-173035260
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr4:173009768-173010010	K562	blood:	n/a	n/a
2	ATF3	chr4:172963829-172964376	HCT-116	colon:	n/a	n/a
3	ATF3	chr4:172964033-172964313	K562	blood:	n/a	n/a
4	BHLHE40	chr4:172955266-172955458	GM12878	blood:	n/a	n/a
5	BHLHE40	chr4:173009843-173010043	K562	blood:	n/a	n/a
6	CBX3	chr4:173027059-173027430	K562	blood:	n/a	n/a
7	CBX3	chr4:173027118-173027368	K562	blood:	n/a	n/a
8	CCNT2	chr4:173033010-173033202	K562	blood:	n/a	n/a
9	CEBPB	chr4:172982512-172982741	HepG2	liver:	n/a	chr4:172982587-172982600 chr4:172982589-172982600 chr4:172982585-172982596 chr4:172982587-172982598
10	CEBPB	chr4:172967123-172967427	K562	blood:	n/a	chr4:172967347-172967358 chr4:172967303-172967314
11	CEBPB	chr4:173004566-173004925	Hela-S3	cervix:	n/a	n/a
12	CEBPB	chr4:173001535-173001557	H1-hESC	embryonic stem cell:	n/a	n/a
13	CEBPB	chr4:172963774-172964388	Hela-S3	cervix:	n/a	n/a
14	CEBPB	chr4:172963777-172964413	HCT-116	colon:	n/a	n/a
15	CEBPB	chr4:172963919-172964070	K562	blood:	n/a	n/a
16	CEBPB	chr4:172982433-172982704	Hela-S3	cervix:	n/a	chr4:172982587-172982600 chr4:172982589-172982600 chr4:172982585-172982596 chr4:172982587-172982598
17	CEBPB	chr4:173009876-173009993	K562	blood:	n/a	n/a
18	CEBPB	chr4:172963622-172964378	HCT-116	colon:	n/a	n/a
19	CEBPB	chr4:172976992-172977221	HepG2	liver:	n/a	chr4:172977101-172977112
20	CEBPB	chr4:172967154-172967499	A549	lung:	n/a	chr4:172967347-172967358 chr4:172967303-172967314
21	CEBPB	chr4:172967177-172967498	IMR90	lung:	n/a	chr4:172967347-172967358 chr4:172967303-172967314
22	CEBPB	chr4:172967170-172967455	Hela-S3	cervix:	n/a	chr4:172967347-172967358 chr4:172967303-172967314
23	CEBPB	chr4:172967162-172967510	HepG2	liver:	n/a	chr4:172967347-172967358 chr4:172967303-172967314
24	CHD1	chr4:173020701-173020722	H1-hESC	embryonic stem cell:	n/a	n/a
25	CHD2	chr4:172955323-172955408	GM12878	blood:	n/a	n/a
26	CTCF	chr4:172955400-172955550	HAc	cerebellar:	n/a	n/a
27	CTCF	chr4:172972560-172972710	HEK293	kidney:	n/a	n/a
28	CTCF	chr4:172955320-172955470	HEK293	kidney:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
29	CTCF	chr4:172955095-172955746	HCT-116	colon:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
30	CTCF	chr4:172955320-172955470	HepG2	liver:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
31	CTCF	chr4:172955300-172955450	GM12864	blood:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
32	CTCF	chr4:172955320-172955470	RPTEC	kidney:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
33	CTCF	chr4:172955300-172955450	AG10803	skin:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
34	CTCF	chr4:172955262-172955528	GM10266	blood:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
35	CTCF	chr4:172955279-172955496	GM12891	blood:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
36	CTCF	chr4:172955280-172955496	MCF-7	breast:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
37	CTCF	chr4:172955340-172955490	GM12864	blood:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
38	CTCF	chr4:172955340-172955490	HCT-116	colon:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
39	CTCF	chr4:172955340-172955490	K562	blood:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
40	CTCF	chr4:172955260-172955410	GM12866	blood:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
41	CTCF	chr4:172955300-172955450	WERI-Rb-1	eye:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
42	CTCF	chr4:172955700-172955850	GM12873	blood:	n/a	n/a
43	CTCF	chr4:172955282-172955492	MCF-7	breast:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
44	CTCF	chr4:172955340-172955490	HVMF	connective:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
45	CTCF	chr4:172955300-172955450	AG09309	skin:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
46	CTCF	chr4:172955300-172955450	HRE	kidney:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
47	CTCF	chr4:172955340-172955490	HL-60	blood:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
48	CTCF	chr4:172955340-172955490	A549	lung:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
49	CTCF	chr4:172955300-172955450	HMF	breast:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
50	CTCF	chr4:172955180-172955505	H1-hESC	embryonic stem cell:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403

No.	Distal block	Cell Line	Cell type
1	chr4:172988137..172989930-chr4:172993221..172995055,2	K562	blood:
2	chr4:173013361..173016115-chr4:173021036..173022697,2	K562	blood:
3	chr4:172977943..172980712-chr4:172981081..172983923,2	K562	blood:
4	chr4:173013361..173016115-chr4:173021036..173022697,2	K562	blood:
5	chr4:173021211..173023179-chr4:173025772..173028444,2	K562	blood:
6	chr4:172962947..172965633-chr4:172966859..172970006,3	K562	blood:
7	chr4:173007639..173009652-chr4:173056667..173058243,2	K562	blood:
8	chr4:172979164..172981714-chr4:172998153..173000134,2	K562	blood:
9	chr4:172968051..172969692-chr4:172971526..172973256,2	K562	blood:
10	chr4:172968051..172969692-chr4:172971526..172973256,2	K562	blood:
11	chr4:171180744..171181463-chr4:172955220..172956289,3	MCF-7	breast:
12	chr4:172955374..172956340-chr4:173068552..173069236,2	MCF-7	breast:
13	chr4:173021211..173023179-chr4:173025772..173028444,2	K562	blood:
14	chr4:172988137..172989930-chr4:172993221..172995055,2	K562	blood:
15	chr4:173025369..173026870-chr4:173057043..173059254,2	K562	blood:
16	chr4:173021131..173023311-chr4:173023529..173025605,2	K562	blood:
17	chr4:172979164..172981714-chr4:172998153..173000134,2	K562	blood:
18	chr4:173021131..173023311-chr4:173023529..173025605,2	K562	blood:
19	chr4:172977943..172980712-chr4:172981081..172983923,2	K562	blood:
20	chr4:172962947..172965633-chr4:172966859..172970006,3	K562	blood:
21	chr4:172767155..172768332-chr4:172954944..172955895,5	MCF-7	breast:
22	chr4:172978945..172981586-chr4:173074547..173076699,2	K562	blood:
23	chr2:166764007..166764674-chr4:172977172..172977832,2	MCF-7	breast:

Variant related genes	Relation type
GALNTL6	TF binding region
ENSG00000123607	chromatin interactions

Extended variants
information (count: 1747 )
Associated
traits (count: 73 )

Variant overlapped rSNPs/rCNVs (count:1747 , 50 per page) page: 1 2 3 4 5 6 7 ... 35

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7656738	chr4:172932137-172932138	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs545846610	chr4:172932175-172932176	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs7661853	chr4:172932202-172932203	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs182578212	chr4:172932209-172932210	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs530237272	chr4:172932264-172932265	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs575492290	chr4:172932286-172932287	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs372702464	chr4:172932313-172932314	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs13133975	chr4:172932320-172932321	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs149527971	chr4:172932414-172932415	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs542426757	chr4:172932435-172932436	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs111753990	chr4:172932436-172932437	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs143191700	chr4:172932438-172932439	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs76322286	chr4:172932498-172932499	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs148075204	chr4:172932507-172932508	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs141837708	chr4:172932510-172932511	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs554756474	chr4:172932534-172932535	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs573374888	chr4:172932538-172932539	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs542342792	chr4:172932548-172932549	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs555725599	chr4:172932596-172932597	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs554899802	chr4:172932650-172932651	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs562386982	chr4:172932734-172932735	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs576029229	chr4:172932747-172932748	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs34006557	chr4:172932772-172932773	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs565143804	chr4:172932801-172932802	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs201552406	chr4:172932806-172932807	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs386682112	chr4:172932808-172932809	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs10031938	chr4:172932810-172932811	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs372035657	chr4:172932845-172932846	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs539855251	chr4:172932906-172932907	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs10032030	chr4:172932912-172932913	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs10029618	chr4:172932937-172932938	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs545863347	chr4:172932982-172932983	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs550336080	chr4:172933018-172933019	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs191291961	chr4:172933025-172933026	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs533002179	chr4:172933099-172933100	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs146073292	chr4:172933140-172933141	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs546707404	chr4:172933147-172933148	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs140067718	chr4:172933152-172933153	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs142067062	chr4:172933159-172933160	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs548520172	chr4:172933198-172933199	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs4493496	chr4:172933229-172933230	Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs9995417	chr4:172933271-172933272	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs568350891	chr4:172933294-172933295	Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs184543686	chr4:172933304-172933305	Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs555889453	chr4:172933309-172933310	Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs576061677	chr4:172933326-172933327	Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs538590257	chr4:172933351-172933352	Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs10030036	chr4:172933370-172933371	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs10030115	chr4:172933380-172933381	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs541369355	chr4:172933460-172933461	Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:73)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Wilms tumour	21544195	CNVD
Lung cancer	18438408	CNVD
Cancer	22429812	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Breast cancer	16272173	CNVD
Breast cancer	17133270	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Congenital anomalies of the kidney and urinary tract	20505237	CNVD
Testicular germ cell tumor	18059402	CNVD
Ovarian cancer	22174824	CNVD
Olfactory neuroblastoma	18408657	CNVD
Breast cancer	21785460	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	21633010	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20581869	CNVD
Hepatocellular carcinoma	16750200	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
abnormal development	18461090	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Neuroblastoma	16790693	CNVD
Schizophrenia	23813976	CNVD
Lung cancer	16773561	CNVD
Colorectal cancer	16774939	CNVD
Myelofibrosis	22110671	CNVD
Developmental delay	22127048	CNVD
Glioblastoma multiforme	22286061	CNVD
Neuroblastoma	21899760	CNVD
Gastric adenocarcinoma	19115996	CNVD
Urothelial carcinoma	21177765	CNVD
Prostate cancer	22341455	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:115 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:172929000-172933400	Enhancers	iPS-18 Cell Line	embryonic stem cell
2	chr4:172930000-172933200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
3	chr4:172930600-172933200	Weak transcription	H9 Cell Line	embryonic stem cell
4	chr4:172931200-172932200	Enhancers	iPS-20b Cell Line	embryonic stem cell
5	chr4:172931200-172933800	Enhancers	ES-I3 Cell Line	embryonic stem cell
6	chr4:172931400-172932200	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
7	chr4:172932000-172932200	Enhancers	iPS-15b Cell Line	embryonic stem cell
8	chr4:172932000-172932400	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
9	chr4:172932000-172933400	Enhancers	HUES6 Cell Line	embryonic stem cell
10	chr4:172932200-172932400	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
11	chr4:172932200-172932600	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
12	chr4:172932200-172933800	Enhancers	HUES64 Cell Line	embryonic stem cell
13	chr4:172932400-172932600	Enhancers	Primary hematopoietic stem cells short term culture	blood
14	chr4:172932400-172932800	Enhancers	Dnd41	blood
15	chr4:172932400-172933600	Enhancers	HUES48 Cell Line	embryonic stem cell
16	chr4:172932400-172933600	Enhancers	iPS-15b Cell Line	embryonic stem cell
17	chr4:172932600-172933400	Enhancers	iPS-20b Cell Line	embryonic stem cell
18	chr4:172933200-172933600	Enhancers	H1 Cell Line	embryonic stem cell
19	chr4:172933200-172933600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
20	chr4:172933200-172933800	Enhancers	H9 Cell Line	embryonic stem cell
21	chr4:172938000-172939400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
22	chr4:172938800-172940200	Enhancers	HMEC	breast
23	chr4:172939200-172940000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
24	chr4:172946600-172947000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
25	chr4:172964000-172964600	Enhancers	Hela-S3	cervix
26	chr4:172965000-172965400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
27	chr4:172965400-172965600	Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
28	chr4:172965400-172965800	Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
29	chr4:172965400-172966200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
30	chr4:172965600-172965800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
31	chr4:172965800-172966000	Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
32	chr4:172966000-172968000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
33	chr4:172966200-172968200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
34	chr4:172968000-172968600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
35	chr4:172968000-172969200	Active TSS	Pancreatic Islets	Pancreatic Islet
36	chr4:172968200-172968600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
37	chr4:172968600-172968800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
38	chr4:172968600-172969200	Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
39	chr4:172968800-172970400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
40	chr4:172969200-172969400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
41	chr4:172969200-172969400	Flanking Active TSS	Pancreatic Islets	Pancreatic Islet
42	chr4:172969200-172970200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
43	chr4:172969400-172970200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
44	chr4:172970200-172970800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
45	chr4:172970400-172970800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
46	chr4:172970800-172972000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
47	chr4:172970800-172972400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
48	chr4:172972000-172973000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
49	chr4:172972200-172972600	Enhancers	Gastric	stomach
50	chr4:172972200-172972800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links